ProCE Banner Activity

CE / CME

Improving Management of Atopic Dermatitis in Children and Adults Through Transition of Care – Part 2

Video

Atopic dermatitis (AD) affects people of all ages, races, ethnicities and has a substantial psychosocial impact on patients and their relatives. AD affects significant numbers of patients who are either children or young adults. With no cure, patients will continue to face ongoing symptoms and, therefore, require continual evaluation, treatment, and disease management strategies as they transition into adulthood. However, dermatology healthcare professionals providing care for younger patients with AD need education on strategies regarding formally transitioning care from a pediatric to an adult-focused AD provider, as this topic has very limited evidence in the medical literature. Tune in for part 2 of this 3-part, on-demand webcast series to hear expert insights on how healthcare teams can facilitate seamless transitions from pediatric to adult AD care and navigating complex cases.

Nurse Practitioners: 0.50 Nursing contact hours, includes 0.50 hour of pharmacotherapy credit

Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit

Physicians: Maximum of 0.50 AMA PRA Category 1 Credit

Released: January 05, 2023

Expiration: January 04, 2024

No longer available for credit.

Share

Faculty

Victoria Garcia-Albea

Victoria Garcia-Albea, NP, DCNP

Director
Lahey Dermatology Nurse Practitioner Training Program
Lahey Hospital and Medical Center
Burlington, Massachusetts

Robert Sidbury

Robert Sidbury, MD, MPH

Professor, Department of Pediatrics
Chief, Division of Dermatology
Seattle Childrens Hospital
University of Washington School of Medicine
Seattle, Washington

Benjamin Ungar

Benjamin Ungar, MD

Assistant Professor
Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, New York

Provided by

ProCE Banner
ProCE Banner

Supporters

Supported by educational grants from Incyte and Sanofi and Regeneron Pharmaceuticals.

Incyte

Sanofi and Regeneron Pharmaceuticals

Target Audience

Dermatologists and NPs, PAs, and nurses who practice in dermatology

Learning Objectives

Upon completion of this activity, participants should be able to:

  •  Discuss the components, goals, and benefits of an effective transition from pediatric to adult atopic dermatitis care with adolescent and young adult patients and their caregivers

Disclosure

All faculty and planners participating in continuing education activities sponsored by Clinical Care Options, LLC (CCO) and Partners for Advancing Clinical Education (PACE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to CCO and PACE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Victoria Garcia-Albea, NP, DCNP: consultant/advisor/speaker: Sanofi-Genzyme.

Kristine Kucera, PA-C, MPAS, DHSc: consultant/advisor/speaker: AbbVie, Amgen, Beiersdorf, Bristol-Myers Squibb, Dermavant, Leo, Novartis, Sun, UCB.

Robert Sidbury, MD, MPH: consultant/advisor/speaker: Beiersdorf, Leo, Lilly.

Benjamin Ungar, MD: consultant/advisor/speaker: Arcutis, Castle Biosciences; researcher: Incyte, Pfizer, Rapt Therapeutics.

The planners and content peer reviewers from Clinical Care Options, LLC, Partners for Advancing Clinical Education, and Practicing Clinicians Exchange do not have any relevant financial relationships to disclose, except Victoria Garcia-Albea, NP, DCNP and Kristine Kucera, PA-C, MPAS, DHSc, as noted above.

 

Instructions for Credit

Learners wishing to earn CE/CME credit must:  

  1. View the content in its entirety
  2. Relate the content material to the learning objectives
  3. Complete evaluation form 

The estimated time to complete this activity is 0.50 hours.

Format

This program has been made available online.

Disclaimer

The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Clinical Care Options, LLC, Partners for Advancing Clinical Education, Practicing Clinicians Exchange, or any educational supporter.

Accreditation

Joint Accreditation Statement
Joint AccreditationIn support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for
Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Physician Continuing Medical Education
CCO designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Joint Accreditation Statement
Joint AccreditationIn support of improving patient care, Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

ANCC Credit Designation
Nursing contact hours: 0.50, which includes 0.50 hours of pharmacology credit
NP course advisor: Victoria Garcia-Albea, NP, DCNP, Lahey Hospital and Medical Center, Burlington, Massachusetts

 

AAPA Credit Designation
Joint AccreditationPartners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.50 AAPA Category 1 CME credit. Approval is valid until January 04, 2024. PAs should only claim credit commensurate with the extent of their participation. 

PA course advisor: Kristine Kucera, PA-C, MPAS, DHSc, UT Southwestern Medical Center, Dallas Texas

 

IPCE Credit Designation
IPCEThis activity was planned by and for the healthcare team, and learners will receive 0.50 Interprofessional Continuing Education (IPCE) credits for learning and change.